List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated
IVD
Cipla’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Revised Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) Published
M
The EOI for artesunate/pyronaridine products is being revised to bring it in line with currently available artesunate/pyronaridine comparator products.
First molnupiravir active pharmaceutical ingredient (API) prequalified
M
Molnupiravir (WHOAPI-451) manufactured by Divi’s Laboratories Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalif